BAJAJ BROKING
The stock market is a dynamic entity with sectors that periodically come into focus. Today, we delve into the pharmaceutical sector, identifying stocks to buy. With a mix of technical analysis and fundamental insights, Bajaj Broking’s Research Desk has come up with a comprehensive overview of the top picks in the pharma sector.
The pharmaceutical sector is on an upward trajectory, driven by robust domestic demand and international acclaim for Indian pharmaceuticals. Known as the 'Pharmacy of the World,' India's pharma industry is poised for significant growth. This blog highlights key stocks in this sector that offer promising returns.
Nifty Pharma: Range Breakout
The Nifty Pharma index has recently broken out of a four-month range, indicating a resumption of its upward trend. This breakout provides a fresh entry opportunity for investors looking to capitalize on the momentum.
Bajaj Broking’s Research Desk anticipates the index to rise towards the 23,900 level, matching the price parity of the previous rally (14,544-19,397) as projected from the recent trough of 17,904.
Fundamental Outlook
India has solidified its position as a global centre for medical tourism, offering affordable treatments with cutting-edge technology, driven by numerous groundbreaking reforms and provisions. Indian medicines, known for their low cost and high quality, are favored worldwide, earning the country the title of the 'Pharmacy of the World.’ The domestic pharmaceutical industry is projected to reach US$ 57 billion by FY25, with an expected increase in operating margins of 100-150 basis points (bps).
1. Sun Pharma
Market Cap: ₹3,76,036 Cr
Sun Pharma is a leader in the domestic pharmaceutical market, driven by volume growth and new product launches. The company is expected to see significant gains due to its strategic moves and strong market presence.
Recommendation:
Technical Outlook:
Fundamental Outlook:
Taro Merger to Strengthen Balance Sheet:
Domestic Business Leadership:
2. Granules India
Market Cap: ₹12,604 Cr
Granules India is transitioning to value-added products, which is driving margins and growth. The company's focus on complex products in regulated markets is set to spur future growth.
Recommendation:
Technical Outlook:
Fundamental Outlook:
Focus on Value-Added Products:
Launch of Complex Products to Spur Growth:
The Sensex after surpassing lifetime highs earlier this week fell by 0.26% to 79,842.21 as of 12:30 PM. The Nifty 50 also saw marginal correction to 24,279.75 as of 12:30 PM on Friday, 5th July. Bank Nifty saw the biggest correction today among indices as it fell by 1% to 52,591.65, driven primarily by HDFC Bank’s 4.4% decline.
Investing in the right stocks requires careful analysis and a keen eye on market trends. Bajaj Broking’s Research Desk helps you with in-depth technical and fundamental analysis of stocks, sectors, trends, and much more. They have identified the pharma sector’s stocks to buy in their latest analysis. Stay tuned for further updates. To stay updated with the markets regularly follow Bajaj Broking’s podcast
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Gold Rate Today | 14 January 2025 | Gold Price in India
14 Jan, 2025 | 40 Min. read
HCL Tech expands partnership with Microsoft to transform contact centres
14 Jan, 2025 | 2 Min. read
BEL secures new orders worth Rs 561 crore, boosting FY25 order book
14 Jan, 2025 | 2 Min. read
ITI Ltd secures Rs 64 crore contracts for Wi-Fi and CCTV systems
14 Jan, 2025 | 2 Min. read
JSW Energy secures LoI for 3.6 GW KSK Mahanadi power plant
14 Jan, 2025 | 2 Min. read
Biocon Biologics’ Johor Bahru Facility Receives FDA VAI Classification
13 Jan, 2025 | 2 Min. read
Interarch Secures ₹221 Crore Projects in Semiconductors & Energy Storage
13 Jan, 2025 | 2 Min. read
DMart Appoints Anshul Asawa as CEO Designate, Succeeding Ignatius Noronha
13 Jan, 2025 | 2 Min. read
JSW Energy Completes ₹630 Crore Acquisition of 125 MW RE Assets
13 Jan, 2025 | 2 Min. read
Laxmi Dental IPO- Key Objective & Deep Analysis
13 Jan, 2025 | 4 Min. read
How to Apply for Sat Kartar Shopping IPO & Check Allotment Status?
13 Jan, 2025 | 1 Min. read
How to Apply for Kabra Jewels IPO & Check Allotment Status?
13 Jan, 2025 | 1 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading